Grant: Strategic Projects - Group
University of Guelph
$126,607.00
Production of a novel resistant starches and evaluation of their human health benefits
EF 2009-10
Résumé
The aims of this proposal are to generate novel RSs through maize and barley breeding programs and evaluate
their human health benefits following ingestion.
Dietary and lifestyle-related diseases such as type-2 diabetes (T2DM), coronary heart disease, obesity and
colonic cancers are major causes of disability and premature death in westernised affluent societies and
emerging nations. Increased consumption of whole grain cereal foods reduces the risk of these conditions
substantially. In particular, resistant starch (RS) which is a component of dietary fibre makes an important
contribution to these benefits by reducing rises in blood sugar levels following ingestion (helping to control
T2DM and reducing factors associated with cardiovascular disease) and acting as a prebiotic, promoting a
healthy lower gut microflora and mitigating incidents of colorectal cancer. RS intakes are low in populations at
high risk of the diseases of affluence, and there is a case for increasing its consumption as an effective means of
improving nutrition for public health at the population level. Replacement of normal starches (which are the
most important source of energy in the human diet) with RSs in daily consumed foods represents an ideal
opportunity to deliver profound health benefits to broad sectors of the population in an acceptable form.
Physicochemical properties of RSs will be determined, and help determine their functionality as potential food
ingredients by Maple Leaf Foods Inc. The RSs produced as a result of this program will also be used as a
valuable source of research material to test hypotheses about the role of amyloplast protein complexes in the
formation of RS structures. Overall, this comprehensive and multidisciplinary study of RS will create novel
germplasm, expand our knowledge in key areas of both human nutritional health and the regulation of storage
starch biosynthesis in plants, and contribute to the improvement of public health.
Programme
Strategic Projects - Group
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
336340-2006
Name nom
Emes, Michael
Department département
Molecular and Cellular Biology
Organization id
24
Institution établissement
University of Guelph
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2009
Competition year année de concours
2006
Award amount
126607
Program id
STPGP
Program nane en
Strategic Projects - Group
Program name fr
Projets stratégiques - De groupe
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1044
Committee name en
Strategic Projects Selection Panel - Food and Bioproducts
Committee name fr
Comité de sélection des projets stratégiques - Aliments et bioproduits
Area of application code
100
Area of application group en
Agriculture and primary food production
Area of application group fr
Agriculture et produits alimentaires primaires
Area of application en
Agriculture and primary food production
Area of application fr
Agriculture et produits alimentaires primaires
Research subject code
6100
Research subject group en
Food science and technology
Research subject group fr
Science et technologie de l'alimentation
Research subject en
Food science and technology
Research subject fr
Science et technologie de l'alimentation
Partie
3
Nb partie
3
Application title
Production of a novel resistant starches and evaluation of their human health benefits
Keyword
NA
Application summary
The aims of this proposal are to generate novel RSs through maize and barley breeding programs and evaluate
their human health benefits following ingestion.
Dietary and lifestyle-related diseases such as type-2 diabetes (T2DM), coronary heart disease, obesity and
colonic cancers are major causes of disability and premature death in westernised affluent societies and
emerging nations. Increased consumption of whole grain cereal foods reduces the risk of these conditions
substantially. In particular, resistant starch (RS) which is a component of dietary fibre makes an important
contribution to these benefits by reducing rises in blood sugar levels following ingestion (helping to control
T2DM and reducing factors associated with cardiovascular disease) and acting as a prebiotic, promoting a
healthy lower gut microflora and mitigating incidents of colorectal cancer. RS intakes are low in populations at
high risk of the diseases of affluence, and there is a case for increasing its consumption as an effective means of
improving nutrition for public health at the population level. Replacement of normal starches (which are the
most important source of energy in the human diet) with RSs in daily consumed foods represents an ideal
opportunity to deliver profound health benefits to broad sectors of the population in an acceptable form.
Physicochemical properties of RSs will be determined, and help determine their functionality as potential food
ingredients by Maple Leaf Foods Inc. The RSs produced as a result of this program will also be used as a
valuable source of research material to test hypotheses about the role of amyloplast protein complexes in the
formation of RS structures. Overall, this comprehensive and multidisciplinary study of RS will create novel
germplasm, expand our knowledge in key areas of both human nutritional health and the regulation of storage
starch biosynthesis in plants, and contribute to the improvement of public health.